Preview

Rheumatology Science and Practice

Advanced search

Gastro-intestinal complications as one of causes of death in patients with rheumatic diseases

https://doi.org/10.14412/1995-4484-2005-614

Abstract

Objective. To assess frequency of gastro-intestinal (Gl) bleeding and ulcer perforation as direct cause of death in pts with rheumatic diseases. Material and methods. Statistical analysis of Tula region patient care institutions documentation was performed to assess frequency and character of severe GI complications leading to death of pts. 300 cases of death which took place during 5 years (1996-2000) in 3 rheumatologic (105 cases) and 10 therapeutic (195 cases) departments of Tula region patient care institutions were studied. Results. Gl bleeding and ulcer perforation were the direct causes of death in 15 pts with rheumatic diseases i.e. in 5% from the whole number of died. GI complications caused death in 4 pts with chronic rheumatic heart disease (HRHD) (1,7%), in 7 (15,2%)with rheumatoid arthritis -, in 2 with ankylosing spondylitis and systemic lupus erythematosus (8,0 and 22,2% respectively). Pts with systemic sclerosis did not die because of GI damage. GI changes most frequently localized in duodenum (8 pts). 4 pts had complications connected with gastric ulcer and in 2 diffuse erosive damage of Gl mucosa was the source of bleeding. Conclusion. Severe Gl complications quite often lead to death of pts with rheumatic diseases in Tula region.

References

1. <div><p>ЗайратьянцО.В. Анализ смертности, летальности, числаау- топсий и качества клинической диагностики в Москве за последнее десятилетие (1991-2000). М., 2002</p><p>Fries J. Non-steroidal anli-inflammatory drug safety: a view from the ARAMIS databank. Curr. Opin. Rheumat. 1996, 9, 3-7.</p><p>Hawkey CJ. Cyclooxygenase inhibition: between the devil and the deep blue sea. Gut, 2002, 50 (suppl. 3), 1125 - 1130</p><p>Шостак H.A., Рябкова A.A., Савельев B.C., Малярова Л.Н. Желудочно-кишечное кровотечение как осложнение гастропатий, связанных с приемом нестероидных противовоспалительных препаратов. Тер. архив, 2003, 5, 70-74</p><p>Laporte J., Ibanez L., Vidal X. et al. Uppergastrointestinal bleeding associated with the use of NSAI Ds: newer versus older / agents. Drug Saf., 2004, 27, 411-420</p><p>Menniti-Ippolito F., Maggini М., Raschetti R. et al. Ketorolac use in outpatients and gastrointestinal hospitalization: a comparison with other non steroidal anti-inflammatory drugs in Italy. Eur. J. Clin. Pharmacol., 1998, 54, 393-397</p><p>Garcia Rodriguez LA., Cattaruzzi C., Troncon M.G., Agostinis L. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other NSAIDs, calcium antagonists, and other antihypertensive drugs. Arch. Intern. Med., 1998, 158, 33-39</p><p>Lipworth L., Friis S., Blot W.J. et al. A population-based cohort study of mortality among users of ibuprofen in Denmark. Am. J. Ther., 2004, 11, 156-163</p></div><br />


Review

For citations:


Sorotskaya V.N., Karateev A.E. Gastro-intestinal complications as one of causes of death in patients with rheumatic diseases. Rheumatology Science and Practice. 2005;43(4):34-37. (In Russ.) https://doi.org/10.14412/1995-4484-2005-614

Views: 1256


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1995-4484 (Print)
ISSN 1995-4492 (Online)